Summary
46 / 100 · Bulios Score
What speaks for it
- The share price is below the Bulios Fair Price.
- It could repay all its net debt from 0.2 years of operating profit.
What to watch
- The company made a loss over the last 12 months.
- Revenue grew by only 6.9% a year over the last 3 years.
- It passes only 3 of the 9 points of the Piotroski financial health test.
- It missed profit estimates 4 times in the last 8 quarters.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks cheapBulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
The company made a loss over the last 12 months, so there is no profit to set the price against.
Valuation in detailIs it growing?
It is shrinkingRevenue (EUR)
Diluted EPS (EUR)
- Analyst estimate
Revenue grew by 7.8% a year over 5 years. Over the last 3 years it grew by 6.9% a year.
Growth in detailDoes it make money?
PoorlyOver the last 12 months it made a loss of 7.69M €.
Profitability in detailIs it financially healthy?
YesIt could repay all its debt from a single year of free cash flow. Its debt is larger than its cash.
Financial health in detailDoes it pay a dividend?
NoIt pays no dividend.
Dividends in detailWhat do analysts expect?
Mildly positive- Buy 2
- Hold 2
- Sell 0
Today's price within the analysts' price targets
The average target of $6 is 445% above today's price. 50% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
Fiscal year 2025By product
The company reports no revenue by product.
By region
- MALTA 24%
- NETHERLANDS 21%
- UNITED STATES 12%
- BRAZIL 12%
- Other Country 11%
- Other 19%
MALTA brings in 24% of revenue.
Segments in detail